AzTrials
AzTrials

Psychosomatic SymptomsMUQ-HIVNCT07833449

The Effect of Murottal Quran on Fatigue Severity Scale and Shatri-Sinulingga Psychosomatic Test Scores in Patients With Human Immunodeficiency Virus Experiencing Psychosomatic Symptoms and Fatigue: A Randomized Controlled Trial

A study testing Quranic Recitation (Murottal) in people with Psychosomatic Symptoms and Fatigue Symptom, run by Universitas Indonesia at 1 site in Indonesia.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This randomized controlled trial evaluates the effect of Quranic recitation (murottal) on psychosomatic symptoms and fatigue in adults living with HIV who have psychosomatic symptoms and fatigue. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Psychosomatic Symptoms, Fatigue Symptom
What is being tested?
Quranic Recitation (Murottal)
Could I receive a placebo?
No, everyone receives an active treatment
How many people
60 participants
Where
1 siteIndonesia
Study dates
20 May 2026to 12 Jul 2026
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Adults aged ≥18 years. Diagnosed with human immunodeficiency virus (HIV) infection. Muslim. HIV clinical stage 1-2. Undetectable HIV viral load. Shatri-Sinulingga Psychosomatic Test (SSPT) score ≥2. Fatigue Severity Scale (FSS) score ≥36. Willing to participate in the study and provide informed consent.

Who cannot join

  • Severe hearing impairment or inability to follow the intervention procedure. Psychotic disorder or depressive disorder requiring psychiatric medication. Pregnancy. Active opportunistic infection. Refusal to participate in the study.

Trial locations and contacts

1 site in 1 country.

Indonesia1 site
  • RSUPN Dr. Cipto Mangunkusumo

    Jakarta, DKI Jakarta, 10430

Other trials in Indonesia

About this study

This randomized controlled trial evaluates the effect of Quranic recitation (murottal) on psychosomatic symptoms and fatigue in adults living with HIV who have psychosomatic symptoms and fatigue. Participants are randomly assigned to either the intervention group, which receives Quranic recitation for approximately 15 minutes, three times per week for 30 days, or the control group. Psychosomatic symptoms and fatigue are assessed before and after the intervention using the Shatri-Sinulingga Psychosomatic Test (SSPT) and Fatigue Severity Scale (FSS), respectively.

Being tested
Quranic Recitation (Murottal)
Medical subject headings
Fatigue

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Quranic Recitation (Murottal)Behavioural

    Participants receive Quranic recitation (murottal) for approximately 15 minutes, three times per week for 30 days (12 sessions).

Study groups in NCT07833449
Study groupRoleWhat they receive
Murottal QuranExperimental15 mins/ 3 times a week for 30 days
Receives: Behavioral: Quranic Recitation (Murottal)
ControlNo interventionStandard care without murottal intervention

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in Shatri-Sinulingga Psychosomatic Test (SSPT) Score

    Measured: Baseline to 30 days after randomization

  2. Change in Fatigue Severity Scale (FSS) Score

    Measured: Baseline to 30 days after randomization

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted22 Sep 2026
  2. Study start20 May 2026
  3. Primary completion12 Jul 2026
  4. Study completion12 Jul 2026

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
60 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07833449
Sponsor's protocol ID
RSCM-IPD-MUROTTAL-HIV-2026
Acronym
MUQ-HIV
Status last verified
Sep 2026
First submitted
16 Sep 2026
Last updated
22 Sep 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Majidi H, Rajabi-Tavakkol A. A Systematic Review of EEG Studies on the Neural Effects of Quran Listening. Iran J Psychiatry. 2025 Apr;20(2):253-264. doi: 10.18502/ijps.v20i2.18206.

    PubMed 40521283
  • Babamohamadi H, Sotodehasl N, Koenig HG, Al Zaben F, Jahani C, Ghorbani R. The Effect of Holy Qur'an Recitation on Depressive Symptoms in Hemodialysis Patients: A Randomized Clinical Trial. J Relig Health. 2017 Feb;56(1):345-354. doi: 10.1007/s10943-016-0281-0.

    PubMed 27393704
  • Babamohamadi H, Sotodehasl N, Koenig HG, Jahani C, Ghorbani R. The Effect of Holy Qur'an Recitation on Anxiety in Hemodialysis Patients: A Randomized Clinical Trial. J Relig Health. 2015 Oct;54(5):1921-30. doi: 10.1007/s10943-014-9997-x.

    PubMed 25559332
  • Barroso J, Leserman J, Harmon JL, Hammill B, Pence BW. Fatigue in HIV-Infected People: A Three-Year Observational Study. J Pain Symptom Manage. 2015 Jul;50(1):69-79. doi: 10.1016/j.jpainsymman.2015.02.006. Epub 2015 Feb 18.

    PubMed 25701691
  • Shatri H, Sinulingga DI, Faisal E, Irvianita V, Putranto R, Ardani Y, Erlita D, Jeger DP, Browijoyo IA. Validity and reliability testing of the Shatri Sinulingga psychosomatic test (SSPT) questionnaire as a screening instrument for psychosomatic disorders in Indonesia. Narra J. 2024 Dec;4(3):e1373. doi: 10.1042/narra.v4i3.1373. Epub 2024 Nov 8.

    PubMed 39816117

Questions about this trial

What is this clinical trial studying?

A study testing Quranic Recitation (Murottal) in people with Psychosomatic Symptoms and Fatigue Symptom, run by Universitas Indonesia at 1 site in Indonesia.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 22 Sep 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Indonesia. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in Shatri-Sinulingga Psychosomatic Test (SSPT) Score (time frame: Baseline to 30 days after randomization). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07833449, which also lists 5 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 22 Sep 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in